Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be announcing earnings results tomorrow before market open. Here’s what you need to know. Lantheus beat analysts’ revenue ...

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $372.8 million. The company’s full ...

BEDFORD, Mass. - Lantheus Holdings, Inc. (NASDAQ: LNTH), a leading company in the radiopharmaceutical field with a market capitalization of $7.2 billion and impressive 18% revenue growth over the ...

You know it's going get to the tumor, and then if you can attach basically a warhead to it, then you know, you can deliver targeted radiation to that tumor,” Lantheus’ CEO Brian Markison says ...

Lantheus Holdings (NASDAQ:LNTH) shares plunged on Wednesday after the maker of diagnostic imaging agents lowered its full-year guidance and reported Q1 2025 results below expectations. The stock ...

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Lantheus Holdings Inc. (LNTH) on Wednesday reported first-quarter earnings of $72.9 million. On a per-share basis, the Bedford, Massachusetts-based ...

Lantheus shares fell 25% post-Q1 2025 report due to disappointing EPS guidance and not meet analysts' expectations. EPS reduction was driven by flat PYLARIFY sales and changes in Medicare coverage ...